Biallelic mutations in ATM cause the recessive disorder ataxia-telangiectasia that is characterized by an increased susceptibility to cancer, but the link between single-copy ATM mutations and cancer has been more difficult to establish. New studies implicate missense mutations in ATM and suggest a model based on dominant interference in heterozygotes.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Synchronous invasive ductal carcinoma and intravascular large B-cell lymphoma of the breast: a case report and review of the literature
World Journal of Surgical Oncology Open Access 08 April 2014
-
Comprehensive analysis of the ATM, CHEK2 and ERBB2genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study
Breast Cancer Research Open Access 28 November 2006
-
Atm heterozygous deficiency enhances development of mammary carcinomas in p53heterozygous knockout mice
Breast Cancer Research Open Access 10 December 2004
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Swift, M., Sholman, L., Perry, M. & Chase, C. Cancer Res. 36, 209–215 (1976).
Spring, K. et al. Nature Genet. 32 (2002); advance online publication, 26 August 2002 (doi:10.1038/ng958).
Swift, M., Morrell, D., Massey, R.B. & Chase, C.L. N. Engl. J. Med. 325, 1831–1836 (1991).
Geoffroy-Perez, B. et al. Int. J. Cancer 93, 288–293 (2001).
Inskip, H.M., Kinlen, L.J., Taylor, A.M., Woods, C.G. & Arlett, C.F. Br. J. Cancer 79, 1304–1307 (1999).
Olsen, J.H. et al. J. Natl Cancer Inst. 93, 121–127 (2001).
Swift, M., Reitnauer, P.J., Morrell, D. & Chase, C.L. N. Engl. J. Med. 316, 1289–1294 (1987).
Athma, P., Rappaport, R. & Swift, M. Cancer Genet. Cytogenet. 92, 130–134 (1996).
FitzGerald, M.G. et al. Nature Genet. 15, 307–310 (1997).
Gatti, R.A., Tward, A. & Concannon, P. Mol. Genet. Metab. 68, 419–423 (1999).
Dork, T. et al. Cancer Res. 61, 7608–7615 (2001).
Teraoka, S.N. et al. Cancer 92, 479–487 (2001).
Chenevix-Trench, G. et al. J. Natl Cancer Inst. 94, 205–215 (2002).
Stankovic, T. et al. Am. J. Hum. Genet. 62, 334–345 (1998).
Scott, S.P. et al. Proc. Natl Acad. Sci. USA 99, 925–930 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Concannon, P. ATM heterozygosity and cancer risk. Nat Genet 32, 89–90 (2002). https://doi.org/10.1038/ng0902-89
Issue Date:
DOI: https://doi.org/10.1038/ng0902-89
This article is cited by
-
Cancer genetics, precision prevention and a call to action
Nature Genetics (2018)
-
Synchronous invasive ductal carcinoma and intravascular large B-cell lymphoma of the breast: a case report and review of the literature
World Journal of Surgical Oncology (2014)
-
Comprehensive analysis of the ATM, CHEK2 and ERBB2genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study
Breast Cancer Research (2006)
-
ATM mutations associated with breast cancer
Breast Cancer Research (2005)
-
Alterations of DNA damage-response genes ATM and ATR in pyothorax-associated lymphoma
Laboratory Investigation (2005)